Blue Arbor wins FDA breakthrough nod for neuromuscular interface
Blue Arbor Technologies announced today that it received FDA breakthrough device designation for its Restore neuromuscular interface system.
Blue Arbor Technologies announced today that it received FDA breakthrough device designation for its Restore neuromuscular interface system.
“It’s not just about the babies for them, it is about the experience for the mother,” says grandma.
Less than 72 hours after the launch of a reporting form to help Utah enforce its transgender bathroom ban, the Utah auditor’s office says it…
Binh Nguyen and colleagues, use longitudinally collected data and target trial emulation methods to explore the impact of mid-life physical activity on the health outcomes…
Internet Society’s Robin Wilton tells us the war on privacy won’t be won by the plod
As we enter the digital era of healthcare at scale, we must redefine how we care for people … and how we evaluate that care.
Health reporter Aaron Derfel has been honoured with the 2024 Medical Journalism Award for his stories on Quebec’s emergency-room crisis.
Extensive testing of pasteurized commercially purchased milk and other dairy products from 38 states found no evidence of live H5N1 bird flu virus.
Interrogating data of monozygotic twins discordant for multiple sclerosis (MS), Ingelfinger et al. identify decreased frequency of blood CXCR3+ B cells as a non-inheritable feature in…
Decision-makers considering using cost-effectiveness analysis (CEA) to inform health-technology assessment (HTA) must contend with documented and controversial shortfalls of CEA, including its assumption of disease…
THURSDAY, May 2, 2024 (HealthDay News) — The U.S. Environmental Protection Agency (EPA) said it will spend $3 billion to help states and territories identify…